Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
Business Of Biotech
00:00
The Progress of a European Company in Clinical Trials
I mentioned in the intro to the episode that you recently emerged from an FDA clinical hold. Congratulations on that, by the way. Despite that hold, the company's progress towards phase three trials has been relatively quick. What advice would you give other bio pharma leaders who have a stumbling block along the way?
Transcript
Play full episode
